Autori: Petzer Andreas L
Naslov | High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients - final analysis of a randomized, multicenter, phase III trial (Article) |
Autori | Petzer Andreas L ... Bogdanovic Andrija D ... (broj koautora 20) |
Info | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, (2012), vol. 97 br. 10, str. 1562-1569 |
Projekat | Novartis |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Pre-treated CML Patients in chronic phase (CP) not achieving at least a major cytogenetic remission (MCyR) after imatinib high dose (HD) induction (800 mg/day, 6 months) are at high risk of progression after dose reduction - Sub-analyses from the CELSG phase III "ISTAHIT" trial (Meeting Abstract) |
Autori | Petzer Andreas L Fong Dominic Lion Thomas Dyagil Irina Masliak Zvenyslava Bogdanovic Andrija D Griskevicius Laimonas Lejniece Sandra Goranov Stefan Gercheva Liana Stojanovic Aleksandar Peytchev Dontcho Tzvetkov Nikolay Griniute Rasa Oucheva Radka Grubinger T Kwakkelstein Marthin Rancati Francesca Gastl Guenther A Wolf Dominik |
Info | ONKOLOGIE, (2011), vol. 34 br. , Suppl. 6, str. 264-264 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Significantly higher and more rapid cytogenetic and molecular responses can be achieved in pre-treated chronic phase CML patients with high doses of Imatinib as induction therapy (800 mg/day, 6 months) - final results of a Phase III CELSG CML11 "ISTAHIT" TRIAL (Meeting Abstract) |
Autori | Petzer Andreas L ... Bogdanovic Andrija D ... (broj koautora 20) |
Info | ONKOLOGIE, (2010), vol. 33 br. , Suppl. Suppl. 6, str. 83-83 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | High Dose Imatinib Induction (800 Mg/day, 6 Months) Induces Significantly Higher Cytogenetic and Molecular Responses in Pre-treated Chronic Phase CML -phase III Celsg 'istahit' Trial - First Results (Meeting Abstract) |
Autori | Petzer Andreas L ... Bogdanovic Andrija D ... Stojanovic Aleksandar ... (broj koautora 20) |
Info | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, (2010), vol. 95 br. , Suppl. Suppl. 2, str. 0133- |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study (Article) |
Autori | Petzer Andreas L Wolf Dominik Fong Dominic Lion Thomas Dyagil Irina Masliak Zvenyslava Bogdanovic Andrija D Griskevicius Laimonas Lejniece Sandra Goranov Stefan Gercheva Liana Stojanovic Aleksandar Peytchev Dontcho Tzvetkov Nikolay Griniute Rasa Oucheva Radka Ulmer Hanno Kwakkelstein Marthin Rancati Francesca Gastl Guenther A |
Info | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, (2010), vol. 95 br. 6, str. 908-913 |
Projekat | Novartis |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Celsg Cml 11 "Istahit" Phase Iii Study - Planned Interim Analysis: High Doses Of Imatinib Mesylate (800mg/Day) Significantly Improve Rates Of Major And Complete Cytogenetic Remissions (Mcr, Ccr) In Pretreated Ph+/Bcr-Abl(+) Cml Patients In Chronic Phase (Meeting Abstract) |
Autori | Petzer Andreas L Boskovic Darinka V Gastl Guenther A |
Info | BLOOD, (2008), vol. 112 br. 11, str. 406-406 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Multicenter, randomized, phase III study comparing imatinib (Glivec) standard dose (400 mg/d) with imatinib high dose induction (800 mg/d) followed by imatinib maintenance (400 mg/d) in patients with pretreated Ph+/BCR-ABL(+) CML in chronic phase - Results from the first planned interim analysis (CELSG-CML 11 ISTAHIT study) (Meeting Abstract) |
Autori | Petzer Andreas L Wolf Dominik Fong Dominic Lion Thomas Dyagil Irina Masliak Zvenyslava Boskovic Darinka V Griskevicius Laimonas Lejniece Sandra Spasov Emil Gercheva Liana Stojanovic Aleksandar Peytchev Dontcho Tzvetkov Nikolay Griniute Rasa Stanchev Atanas Kwakkelstein Martin Ulmer Hanno Gastl Guenther A |
Info | BLOOD, (2007), vol. 110 br. 11, str. 317A-317A |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|